Valeo Financial Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Sell
5,206
-1,462
-22% -$97.4K 0.01% 563
2026
Q1
$419K Sell
6,668
-158
-2% -$11K 0.01% 456
2025
Q4
$453K Sell
6,826
-2,588
-27% -$167K 0.01% 493
2025
Q3
$633K Sell
9,414
-1,036
-10% -$82K 0.01% 405
2025
Q2
$912K Buy
10,450
+2,162
+26% +$169K 0.02% 327
2025
Q1
$566K Sell
8,288
-1,267
-13% -$103K 0.02% 386
2024
Q4
$743K Sell
9,555
-486
-5% -$36K 0.02% 329
2024
Q3
$673K Buy
10,041
+2,424
+32% +$199K 0.02% 340
2024
Q2
$864K Buy
7,617
+2,062
+37% +$261K 0.03% 268
2024
Q1
$766K Buy
5,555
+828
+18% +$104K 0.03% 281
2023
Q4
$587K Buy
4,727
+2,363
+100% +$241K 0.02% 318
2023
Q3
$221K Buy
2,364
+721
+44% +$81.3K 0.01% 537
2023
Q2
$211K Buy
+1,643
New +$199K 0.01% 531
2021
Q2
Sell
-304
Closed -$27K 856
2021
Q1
$27K Sell
304
-96
-24% -$9.01K ﹤0.01% 1060
2020
Q4
$37K Buy
400
+76
+23% +$6.79K ﹤0.01% 874
2020
Q3
$33K Sell
324
-300
-48% -$31.3K ﹤0.01% 780
2020
Q2
$63K Buy
624
+308
+97% +$27.6K 0.01% 643
2020
Q1
$20K Buy
316
+288
+1,029% +$17.9K ﹤0.01% 896
2019
Q4
$2K Sell
28
-100
-78% -$4.74K ﹤0.01% 1443
2019
Q3
$5K Buy
128
+28
+28% +$1.09K ﹤0.01% 1190
2019
Q2
$4K Sell
100
-120
-55% -$3.77K ﹤0.01% 1254
2019
Q1
$7K Buy
+220
New +$7.73K ﹤0.01% 1048
2018
Q4
Sell
-80
Closed -$2.54K 1548
2018
Q3
$3K Hold
80
﹤0.01% 1337
2018
Q2
$2K Hold
80
﹤0.01% 1331
2018
Q1
$1K Hold
80
﹤0.01% 1418
2017
Q4
$1K Buy
+80
New +$1.04K ﹤0.01% 1265

Other funds holding DXCM

Valeo Financial Advisors's DXCM Position: Q2 2026 in Review

Valeo Financial Advisors reduced its DexCom (DXCM) stake by 22% in Q2 2026, selling an estimated $97.4K and leaving 5,206 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #563.

Valeo Financial Advisors first reported a position in DXCM in Q4 2017 and has held it in 26 quarters since. The position peaked at $912K in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Valeo Financial Advisors held 5,206 shares of DexCom worth $351K as of Q2 2026.
  • Valeo Financial Advisors sold 1,462 DexCom shares in Q2 2026, an estimated $97.4K.
  • DexCom made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #563 holding.
  • Valeo Financial Advisors first reported a position in DexCom in Q4 2017 and has held it in 26 quarters since.
  • Valeo Financial Advisors's DexCom position peaked at $912K in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.